Work

Tinengotinib, an arising option for FGFR inhibitor resistant cholangiocarcinoma

Year: 2026

Type: article

Source: Journal of Gastrointestinal Oncology

DOI: 10.21037/jgo-2026-0776

Author: Ioannis A. Voutsadakis

Institutions: University of Iowa, University of Iowa Hospitals and Clinics, University of Iowa Health Care, University of Iowa Holden Comprehensive Cancer Center, NOSM University

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W7224105317

FWCI:

Cites:

Cited by:

Related to: 10